Another report for Yang et al. [47] showed that GRIA1 is one of the top 10 target genes in the protein–protein interaction network present in the five-miRNA signature model used as a novel prognosis biomarker and therapeutic target for patients with colorectal cancer. This evidence concerns the gene GRIA1 and colorectal cancer.